 However, when haploinsufficient FOXO1 mice were treated with the same HFD, there was a notable decrease in insulin resistance in both skeletal and liver cells.This effect was significantly augmented by the simultaneous administration of rosiglitazone, which is a commonly prescribed anti-diabetic drug.These results create an opportunity for a novel gene therapy based approach to alleviating insulin desensitization in type 2 diabetes.